Skip to Content

B 376 (Imatinib Mesylate 100 mg)

Pill with imprint B 376 is Brown, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Imatinib is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B 376

Imatinib Mesylate

Imprint
B 376
Strength
100 mg
Color
Brown
Shape
Round
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
Manufacturer
Stason Pharmaceuticals, Inc.
National Drug Code (NDC)
51991-0376

Get help with Imprint Code FAQs.

Related Images for "B 376"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.